
Obesity Isn’t A Willpower Problem: The Role Of GLP-1s | Dr. Spencer Nadolsky
The Dr. Tyna Show
Navigating Appetite Control and Industry Concerns in Weight Management
This chapter explores the intricate factors influencing appetite regulation and the significance of maintaining a healthy balance. It also critiques the exploitative practices in the weight loss industry, underscoring the importance of authenticity in medical endorsements.
EP. 212: Today I’m joined by Dr. Spencer Nadolsky, obesity specialist, Lipidologist, and founder of Vineyard, a cutting-edge direct care platform. We’re diving deep into the conversation you’ve been asking for: the real story behind GLP-1s, obesity as a chronic disease, and why treating it goes far beyond weight loss.
We break down everything from proper dosing, common side effects, and the dangers of vanity prescribing to the systemic issues with telemedicine and PBMs. Dr. Nadolsky and I also discuss strength training, preserving muscle mass, and how GLP-1s may support metabolic and cardiovascular health beyond their FDA indications.
This episode cuts through the noise and misinformation. If you care about metabolic health, this one’s essential.
Topics Discussed:
-
What are the real benefits of GLP-1 medications beyond weight loss?
-
Is obesity truly a chronic disease, and how should it be treated?
-
What are the risks of GLP-1 vanity dosing and fast titration?
-
How do GLP-1s impact muscle mass and metabolic health?
-
Why are telemedicine and PBMs problematic for obesity treatment?
Sponsored By:
- Maui Nui Venison | Head to mauinuivenison.com/DRTYNA to secure your access now.
- LMNT | Get your free Sample Pack with any LMNT purchase at drinkLMNT.com/drtyna
- Qualia | Go to qualialife.com/DRTYNA for up to 50% off your purchase and use code DRTYNA for an additional 15%
- Liver Love | Go to https://store.drtyna.com/products/liverlove Use code LIVER20 for 20% off
On This Episode We Cover:
-
00:00:00 – Introduction
-
00:02:48 – GLP-1 Dosing
-
00:06:35 – Side Effects of Vanity Dosing
-
00:08:51 – Reducing GLP-1 Dosing
-
00:12:27 – Med Spas & Telemedicine Risks
-
00:14:20 – Slow Titration for Better Tolerance
-
00:18:44 – Pharma Profits & Overdosing
-
00:20:49 – Obesity Treatment Pre & Post GLP-1s
-
00:27:58 – Obesity Is a Chronic Disease
-
00:32:45 – Defining obesity
-
00:36:16 – The Role of Genetics in Obesity
-
00:38:59 – Lifestyle Factors Beyond Genetics
-
00:40:46 – Insurance Barriers & PBM Costs
-
00:44:37 – Anti-GLP-1 Bias in Healthcare
-
00:46:22 – Why Strength Training Matters
-
00:51:39 – New Doctors & Role of AI
-
00:53:38 – Protecting Muscle on GLP-1s
-
00:58:55 – No Shortcuts to Health
-
01:02:01 – The Vineyard
Show Links:
Further Listening
Check Out Dr. Spencer
Disclaimer: Information provided in this podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional, or any information contained on or in any product. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before taking any medication or nutritional, herbal or other supplement, or using any treatment for a health problem. Information provided in this blog/podcast and the use of any products or services related to this podcast by you does not create a doctor-patient relationship between you and Dr. Tyna Moore. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease.